Literature DB >> 24739902

Epidermal RelA specifically restricts contact allergen-induced inflammation and apoptosis in skin.

Snehlata Kumari1, Benjamin Herzberg2, Ruth Pofahl2, Thomas Krieg2, Ingo Haase2.   

Abstract

Strong inhibition of NF-κB signaling in the epidermis results in spontaneous skin inflammation in mice and men. As there is evidence for linkage between polymorphisms within the NF-κB signaling pathway and human inflammatory skin phenotypes, we asked whether partial functional inhibition of NF-κB signaling in epidermal keratinocytes can modulate clinically relevant skin inflammation. We therefore mutated rela specifically in the epidermis of mice (RelA(E-MUT) mice). These mice show no inflammatory phenotype. Induction of contact allergy, but not croton oil-induced irritant dermatitis, resulted in stronger ear swelling and increased epidermal thickness in RelA(E-MUT) mice. Both contact allergen and croton oil treatment led to increased expression of calgranulins A and B (S100A8/A9) in RelA(E-MUT) mice. Epidermal hyperproliferation in RelA(E-MUT) mice was non-cell autonomous as cultured primary epidermal keratinocytes from RelA(E-MUT) mice showed reduced proliferation compared with controls. These results demonstrate that epidermal RelA specifically regulates delayed-type hypersensitivity-induced skin inflammation. In addition, we describe here an essential but nonspecific function of RelA in the protection of epidermal keratinocytes from apoptosis. Our study identifies functions of NF-κB signaling in the epidermis and corroborates a specific role of epidermal keratinocytes in the regulation of skin inflammation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24739902     DOI: 10.1038/jid.2014.193

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  57 in total

Review 1.  Control of apoptosis by Rel/NF-kappaB transcription factors.

Authors:  M Barkett; T D Gilmore
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

2.  Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.

Authors:  Arianna Nenci; Marion Huth; Alfred Funteh; Marc Schmidt-Supprian; Wilhelm Bloch; Daniel Metzger; Pierre Chambon; Klaus Rajewsky; Thomas Krieg; Ingo Haase; Manolis Pasparakis
Journal:  Hum Mol Genet       Date:  2006-01-06       Impact factor: 6.150

3.  A point mutation in NEMO associated with anhidrotic ectodermal dysplasia with immunodeficiency pathology results in destabilization of the oligomer and reduces lipopolysaccharide- and tumor necrosis factor-mediated NF-kappa B activation.

Authors:  Emilie Vinolo; Hélène Sebban; Alain Chaffotte; Alain Israël; Gilles Courtois; Michel Véron; Fabrice Agou
Journal:  J Biol Chem       Date:  2005-12-26       Impact factor: 5.157

4.  Keratinocyte-specific ablation of the NF-κB regulatory protein A20 (TNFAIP3) reveals a role in the control of epidermal homeostasis.

Authors:  S Lippens; S Lefebvre; B Gilbert; M Sze; M Devos; K Verhelst; L Vereecke; C Mc Guire; C Guérin; P Vandenabeele; M Pasparakis; M L Mikkola; R Beyaert; W Declercq; G van Loo
Journal:  Cell Death Differ       Date:  2011-05-13       Impact factor: 15.828

5.  IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice.

Authors:  J F Klement; N R Rice; B D Car; S J Abbondanzo; G D Powers; P H Bhatt; C H Chen; C A Rosen; C L Stewart
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

6.  Earliest innate immune responses require macrophage RelA during pneumococcal pneumonia.

Authors:  Lynnelle A Pittet; Lee J Quinton; Kazuko Yamamoto; Bryanne E Robson; J Daniel Ferrari; Hana Algül; Roland M Schmid; Joseph P Mizgerd
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-07       Impact factor: 6.914

7.  Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft-versus-host disease.

Authors:  A C Gilliam; D Whitaker-Menezes; R Korngold; G F Murphy
Journal:  J Invest Dermatol       Date:  1996-09       Impact factor: 8.551

8.  Pancreas-specific RelA/p65 truncation increases susceptibility of acini to inflammation-associated cell death following cerulein pancreatitis.

Authors:  Hana Algül; Matthias Treiber; Marina Lesina; Hassan Nakhai; Dieter Saur; Fabian Geisler; Alexander Pfeifer; Stephan Paxian; Roland M Schmid
Journal:  J Clin Invest       Date:  2007-05-24       Impact factor: 14.808

9.  A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.

Authors:  Gilles Courtois; Asma Smahi; Janine Reichenbach; Rainer Döffinger; Caterina Cancrini; Marion Bonnet; Anne Puel; Christine Chable-Bessia; Shoji Yamaoka; Jacqueline Feinberg; Sophie Dupuis-Girod; Christine Bodemer; Susanna Livadiotti; Francesco Novelli; Paolo Rossi; Alain Fischer; Alain Israël; Arnold Munnich; Françoise Le Deist; Jean-Laurent Casanova
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

10.  The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes.

Authors:  Riny Janssen; Annelies van Wengen; Marieke A Hoeve; Monique ten Dam; Miriam van der Burg; Jacques van Dongen; Esther van de Vosse; Maarten van Tol; Robbert Bredius; Tom H Ottenhoff; Corry Weemaes; Jaap T van Dissel; Arjan Lankester
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

View more
  2 in total

1.  Cutting edge: NF-κB p65 and c-Rel control epidermal development and immune homeostasis in the skin.

Authors:  Yenkel Grinberg-Bleyer; Teruki Dainichi; Hyunju Oh; Nicole Heise; Ulf Klein; Roland M Schmid; Matthew S Hayden; Sankar Ghosh
Journal:  J Immunol       Date:  2015-02-13       Impact factor: 5.422

2.  Acute inflammation regulates neuroregeneration through the NF-κB pathway in olfactory epithelium.

Authors:  Mengfei Chen; Randall R Reed; Andrew P Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-10       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.